JPWM
MRNA icon

Jamison Private Wealth Management’s Moderna MRNA Stock Holding History

Jamison Private Wealth Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-334
Closed -$22.3K – 364
2024
Q3 		$22.3K Sell
334
-40
-11% -$3.67K ﹤0.01% 297
2024
Q2 		$44.4K Sell
374
-5
-1% -$633 0.01% 249
2024
Q1 		$40.4K Buy
379
+5
+1% +$504 0.01% 262
2023
Q4 		$37.2K Hold
374
– – 0.01% 249
2023
Q3 		$38.6K Buy
+374
New +$41.7K 0.01% 238

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Jamison Private Wealth Management's MRNA Position: Q4 2024 in Review

Jamison Private Wealth Management sold out of Moderna (MRNA) in Q4 2024, closing a stake of 334 shares — an estimated $22.3K sold.

Jamison Private Wealth Management first reported a position in MRNA in Q3 2023 and held it in 5 quarters. The position peaked at $44.4K in Q2 2024. 745 funds tracked by Wall St. Rank hold MRNA as of Q4 2024.

  • Jamison Private Wealth Management reported no remaining Moderna position as of Q4 2024 after selling out during the quarter.
  • Jamison Private Wealth Management sold 334 Moderna shares in Q4 2024, an estimated $22.3K.
  • Jamison Private Wealth Management first reported a position in Moderna in Q3 2023 and held it in 5 quarters.
  • Jamison Private Wealth Management's Moderna position peaked at $44.4K in Q2 2024.
  • 745 funds tracked by Wall St. Rank held Moderna as of Q4 2024.

Based on Jamison Private Wealth Management's 13F filing for Q4 2024, filed 21 Jan 2025.